Stratos Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Sell
16,159
-61
-0.4% -$5.44K 0.02% 678
2025
Q4
$1.28M Sell
16,220
-68
-0.4% -$5.33K 0.01% 684
2025
Q3
$1.3M Buy
16,288
+419
+3% +$35.7K 0.02% 658
2025
Q2
$1.44M Sell
15,869
-206
-1% -$18.8K 0.02% 584
2025
Q1
$1.51M Sell
16,075
-1,358
-8% -$122K 0.02% 534
2024
Q4
$1.58M Sell
17,433
-3,700
-18% -$353K 0.02% 538
2024
Q3
$2.19M Buy
21,133
+1,382
+7% +$141K 0.03% 437
2024
Q2
$1.92M Sell
19,751
-715
-3% -$66K 0.03% 448
2024
Q1
$1.84M Sell
20,466
-1,041
-5% -$88.2K 0.03% 463
2023
Q4
$1.71M Buy
21,507
+1,181
+6% +$88.8K 0.03% 452
2023
Q3
$1.45M Sell
20,326
-188
-0.9% -$14.1K 0.03% 452
2023
Q2
$1.58M Buy
20,514
+2,064
+11% +$160K 0.04% 398
2023
Q1
$1.39M Sell
18,450
-1,499
-8% -$111K 0.04% 394
2022
Q4
$1.57M Buy
19,949
+2,513
+14% +$188K 0.04% 394
2022
Q3
$1.23M Sell
17,436
-705
-4% -$55.3K 0.03% 427
2022
Q2
$1.45M Buy
18,141
+203
+1% +$15.9K 0.04% 395
2022
Q1
$1.36M Buy
17,938
+1,212
+7% +$96K 0.03% 469
2021
Q4
$1.43M Buy
16,726
+5,495
+49% +$429K 0.03% 458
2021
Q3
$849K Buy
11,231
+1,303
+13% +$103K 0.02% 569
2021
Q2
$808K Sell
9,928
-220
-2% -$18K 0.02% 610
2021
Q1
$800K Sell
10,148
-474
-4% -$37.2K 0.02% 561
2020
Q4
$908K Sell
10,622
-2,362
-18% -$195K 0.03% 475
2020
Q3
$1M Buy
12,984
+417
+3% +$31.8K 0.03% 399
2020
Q2
$921K Sell
12,567
-125
-1% -$8.88K 0.03% 397
2020
Q1
$842K Buy
12,692
+343
+3% +$24.2K 0.04% 373
2019
Q4
$850K Sell
12,349
-344
-3% -$23.5K 0.03% 439
2019
Q3
$933K Buy
12,693
+511
+4% +$37.1K 0.04% 383
2019
Q2
$873K Sell
12,182
-710
-6% -$50.4K 0.04% 404
2019
Q1
$884K Buy
12,892
+203
+2% +$13.1K 0.04% 395
2018
Q4
$755K Sell
12,689
-1,615
-11% -$101K 0.04% 401
2018
Q3
$958K Sell
14,304
-87
-0.6% -$5.79K 0.04% 345
2018
Q2
$933K Sell
14,391
-957
-6% -$62.6K 0.04% 380
2018
Q1
$1.1M Buy
15,348
+2,968
+24% +$214K 0.05% 347
2017
Q4
$934K Buy
12,380
+172
+1% +$12.6K 0.04% 364
2017
Q3
$889K Buy
12,208
+57
+0.5% +$4.11K 0.04% 353
2017
Q2
$901K Buy
12,151
+132
+1% +$9.8K 0.05% 312
2017
Q1
$880K Sell
12,019
-11,090
-48% -$776K 0.05% 305
2016
Q4
$1.51M Buy
23,109
+6,338
+38% +$435K 0.09% 205
2016
Q3
$1.24M Buy
16,771
+6,995
+72% +$517K 0.08% 208
2016
Q2
$716K Buy
9,776
+1,122
+13% +$79.9K 0.05% 267
2016
Q1
$611K Buy
8,654
+1,258
+17% +$83.7K 0.05% 259
2015
Q4
$493K Sell
7,396
-2,429
-25% -$162K 0.04% 308
2015
Q3
$624K Buy
9,825
+4,214
+75% +$275K 0.08% 215
2015
Q2
$367K Sell
5,611
-3,552
-39% -$241K 0.05% 315
2015
Q1
$641K Buy
9,163
+1,262
+16% +$87.2K 0.08% 236
2014
Q4
$547K Buy
7,901
+1,020
+15% +$68.9K 0.1% 213
2014
Q3
$448K Buy
6,881
+493
+8% +$32.5K 0.11% 169
2014
Q2
$433K Buy
+6,388
New +$428K 0.14% 172

Other funds holding CL

Stratos Wealth Partners's CL Position: Q1 2026 in Review

Stratos Wealth Partners reduced its Colgate-Palmolive (CL) stake by 0.38% in Q1 2026, selling an estimated $5.44K and leaving 16,159 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #678.

Stratos Wealth Partners first reported a position in CL in Q2 2014 and has held it in 48 quarters since. The position peaked at $2.19M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Stratos Wealth Partners held 16,159 shares of Colgate-Palmolive worth $1.38M as of Q1 2026.
  • Stratos Wealth Partners sold 61 Colgate-Palmolive shares in Q1 2026, an estimated $5.44K.
  • Colgate-Palmolive made up 0.02% of Stratos Wealth Partners's portfolio in Q1 2026, its #678 holding.
  • Stratos Wealth Partners first reported a position in Colgate-Palmolive in Q2 2014 and has held it in 48 quarters since.
  • Stratos Wealth Partners's Colgate-Palmolive position peaked at $2.19M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.